Viridian Therapeutics, Inc. (VRDN)
NASDAQ: VRDN · Real-Time Price · USD
13.49
-0.07 (-0.52%)
Apr 25, 2025, 4:00 PM EDT - Market closed
Viridian Therapeutics Analyst Ratings
Total Analysts
12
Consensus Rating
Buy
Price Target
$36.44
Upside
+170.13%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $34 | Strong Buy | Reiterates | $34 | +152.04% | Apr 23, 2025 |
| Needham | Needham | Strong Buy Reiterates $38 | Strong Buy | Reiterates | $38 | +181.69% | Jan 7, 2025 |
| Wells Fargo | Wells Fargo | Buy → Hold Downgrades $27 | Buy → Hold | Downgrades | $27 | +100.15% | Dec 19, 2024 |
| RBC Capital | RBC Capital | Buy Maintains $44 → $47 | Buy | Maintains | $44 → $47 | +248.41% | Dec 17, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $34 | Strong Buy | Reiterates | $34 | +152.04% | Dec 17, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $34 | Strong Buy | Reiterates | $34 | +152.04% | Dec 16, 2024 |
| RBC Capital | RBC Capital | Buy Reiterates $44 | Buy | Reiterates | $44 | +226.17% | Dec 5, 2024 |
| Needham | Needham | Strong Buy Reiterates $38 | Strong Buy | Reiterates | $38 | +181.69% | Nov 25, 2024 |
| TD Cowen | TD Cowen | Strong Buy Initiates n/a | Strong Buy | Initiates | n/a | n/a | Nov 25, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $27 → $34 | Strong Buy | Maintains | $27 → $34 | +152.04% | Nov 14, 2024 |
| Needham | Needham | Strong Buy Reiterates $38 | Strong Buy | Reiterates | $38 | +181.69% | Nov 13, 2024 |
| Needham | Needham | Strong Buy Reiterates $38 | Strong Buy | Reiterates | $38 | +181.69% | Oct 28, 2024 |
| BTIG | BTIG | Strong Buy Maintains $56 → $61 | Strong Buy | Maintains | $56 → $61 | +352.19% | Sep 26, 2024 |
| RBC Capital | RBC Capital | Buy Reiterates $44 | Buy | Reiterates | $44 | +226.17% | Sep 19, 2024 |
| RBC Capital | RBC Capital | Buy Maintains $35 → $44 | Buy | Maintains | $35 → $44 | +226.17% | Sep 13, 2024 |
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $25 → $31 | Strong Buy | Maintains | $25 → $31 | +129.80% | Sep 12, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.